Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 155

1.

CD27 is heterogeneously expressed in multiple myeloma: low CD27 expression in patients with high-risk disease.

Guikema JE, Hovenga S, Vellenga E, Conradie JJ, Abdulahad WH, Bekkema R, Smit JW, Zhan F, Shaughnessy J Jr, Bos NA.

Br J Haematol. 2003 Apr;121(1):36-43.

PMID:
12670329
2.

Immunophenotypic characterization of plasma cells from monoclonal gammopathy of undetermined significance patients. Implications for the differential diagnosis between MGUS and multiple myeloma.

Ocqueteau M, Orfao A, Almeida J, Bladé J, González M, García-Sanz R, López-Berges C, Moro MJ, Hernández J, Escribano L, Caballero D, Rozman M, San Miguel JF.

Am J Pathol. 1998 Jun;152(6):1655-65.

3.

A possible role for the loss of CD27-CD70 interaction in myelomagenesis.

Katayama Y, Sakai A, Oue N, Asaoku H, Otsuki T, Shiomomura T, Masuda R, Hino N, Takimoto Y, Imanaka F, Yasui W, Kimura A.

Br J Haematol. 2003 Jan;120(2):223-34.

PMID:
12542479
4.

Generation of polyclonal plasmablasts from peripheral blood B cells: a normal counterpart of malignant plasmablasts.

Tarte K, De Vos J, Thykjaer T, Zhan F, Fiol G, Costes V, Rème T, Legouffe E, Rossi JF, Shaughnessy J Jr, Ørntoft TF, Klein B.

Blood. 2002 Aug 15;100(4):1113-22.

5.

CD19 and immunophenotype of bone marrow plasma cells in monoclonal gammopathy of undetermined significance.

Zandecki M, Facon T, Bernardi F, Izydorczyk V, Dupond L, François M, Reade R, Iaru T, Bauters F, Cosson A.

J Clin Pathol. 1995 Jun;48(6):548-52.

7.
8.

Multiparameter analyses of normal and malignant human plasma cells: CD38++, CD56+, CD54+, cIg+ is the common phenotype of myeloma cells.

Leo R, Boeker M, Peest D, Hein R, Bartl R, Gessner JE, Selbach J, Wacker G, Deicher H.

Ann Hematol. 1992 Mar;64(3):132-9.

PMID:
1373957
9.

Immunophenotypic and DNA content characteristics of plasma cells in multiple myeloma and monoclonal gammopathy of undetermined significance.

Almeida J, Orfao A, Mateo G, Ocqueteau M, García-Sanz R, Moro MJ, Hernandez J, Ortega F, Borrego D, Barez A, Mejido M, San Miguel JF.

Pathol Biol (Paris). 1999 Feb;47(2):119-27. Review.

PMID:
10192879
10.

Soluble urokinase-type plasminogen activator receptor (suPAR) as an independent factor predicting worse prognosis and extra-bone marrow involvement in multiple myeloma patients.

Rigolin GM, Tieghi A, Ciccone M, Bragotti LZ, Cavazzini F, Della Porta M, Castagnari B, Carroccia R, Guerra G, Cuneo A, Castoldi G.

Br J Haematol. 2003 Mar;120(6):953-9.

PMID:
12648064
11.

Lack of CD27 in myeloma delineates different presentation and outcome.

Moreau P, Robillard N, Jégo G, Pellat C, Le Gouill S, Thoumi S, Avet-Loiseau H, Harousseau JL, Bataille R.

Br J Haematol. 2006 Jan;132(2):168-70.

PMID:
16398651
12.

C-kit receptor (CD117) expression on plasma cells in monoclonal gammopathies.

Kraj M, Pogłód R, Kopeć-Szlezak J, Sokołowska U, Woźniak J, Kruk B.

Leuk Lymphoma. 2004 Nov;45(11):2281-9.

PMID:
15512818
13.

Increased expression of CD27 on activated human memory B cells correlates with their commitment to the plasma cell lineage.

Avery DT, Ellyard JI, Mackay F, Corcoran LM, Hodgkin PD, Tangye SG.

J Immunol. 2005 Apr 1;174(7):4034-42. Erratum in: J Immunol. 2005 May 1;174(9):5885.

14.

Fluorescence in situ hybridization analysis of aneuploidization patterns in monoclonal gammopathy of undetermined significance versus multiple myeloma and plasma cell leukemia.

Rasillo A, Tabernero MD, Sánchez ML, Pérez de Andrés M, Martín Ayuso M, Hernández J, Moro MJ, Fernández-Calvo J, Sayagués JM, Bortoluci A, San Miguel JF, Orfao A.

Cancer. 2003 Feb 1;97(3):601-9.

15.

Plasma cells in multiple myeloma express a natural killer cell-associated antigen: CD56 (NKH-1; Leu-19).

Van Camp B, Durie BG, Spier C, De Waele M, Van Riet I, Vela E, Frutiger Y, Richter L, Grogan TM.

Blood. 1990 Jul 15;76(2):377-82.

16.

Low CD27 expression in plasma cell dyscrasias correlates with high-risk disease: an immunohistochemical analysis.

Morgan TK, Zhao S, Chang KL, Haddix TL, Domanay E, Cornbleet PJ, Arber DA, Natkunam Y.

Am J Clin Pathol. 2006 Oct;126(4):545-51.

PMID:
16938662
18.

Flow cytometric detection of aneuploid CD38(++) plasmacells and CD19(+) B-lymphocytes in bone marrow, peripheral blood and PBSC harvest in multiple myeloma patients.

Santonocito AM, Consoli U, Bagnato S, Milone G, Palumbo GA, Di Raimondo F, Stagno F, Guglielmo P, Giustolisi R.

Leuk Res. 2004 May;28(5):469-77.

PMID:
15068900
19.

Dysregulation of CD47 and the ligands thrombospondin 1 and 2 in multiple myeloma.

Rendtlew Danielsen JM, Knudsen LM, Dahl IM, Lodahl M, Rasmussen T.

Br J Haematol. 2007 Sep;138(6):756-60.

PMID:
17760807
20.

Expression of CD28 and CD40 in human myeloma cells: a comparative study with normal plasma cells.

Pellat-Deceunynck C, Bataille R, Robillard N, Harousseau JL, Rapp MJ, Juge-Morineau N, Wijdenes J, Amiot M.

Blood. 1994 Oct 15;84(8):2597-603.

Supplemental Content

Support Center